Novanta Inc.
148.20
2.02 (1.38%)
At close: Jan 14, 2025, 3:59 PM
150.40
1.48%
Pre-market Jan 15, 2025, 04:42 AM EST

Novanta Inc. Revenue Breakdown

Quarter Sep 27, 2024Mar 29, 2024Dec 31, 2023Sep 29, 2023Jun 30, 2023Mar 31, 2023
Medical Solutions Revenue 103.78M 102.45M 80.88M 83.38M 83.32M 77.64M
Medical Solutions Revenue Growth +1.30% +26.67% -2.99% +0.07% +7.32% n/a

Revenue by Geography

Quarter Dec 31, 2023Dec 31, 2022Dec 31, 2021Dec 31, 2020Dec 31, 2019Dec 31, 2018Dec 31, 2017Dec 31, 2016Dec 31, 2015Dec 31, 2014Dec 31, 2013
China Revenue 73.44M 97.18M 95.05M 70.56M 59.51M 66.41M 56.13M 44.23M 14.79M 10.77M 51.35M
China Revenue Growth -24.42% +2.24% +34.71% +18.56% -10.39% +18.33% +26.91% +198.92% +37.32% -79.02% n/a
Germany Revenue 128.23M 133.73M 101.86M 83.77M 82.03M 88.03M 68.00M 55.94M n/a 58.83M n/a
Germany Revenue Growth -4.11% +31.28% +21.61% +2.11% -6.81% +29.45% +21.56% n/a n/a n/a n/a
Other Countries Revenue 19.35M 18.25M 10.99M 9.17M 11.04M 7.75M 10.85M 18.03M n/a 54.31M n/a
Other Countries Revenue Growth +5.99% +66.10% +19.88% -17.00% +42.61% -28.60% -39.83% n/a n/a n/a n/a
Rest Of Asia Pacific Revenue 105.35M 101.60M 89.20M 74.33M 89.59M 104.30M 84.73M 60.10M n/a n/a n/a
Rest Of Asia Pacific Revenue Growth +3.70% +13.90% +20.00% -17.03% -14.11% +23.10% +40.97% n/a n/a n/a n/a
Rest Of Europe Revenue 137.03M 137.80M 138.86M 127.04M 129.64M 105.61M 81.00M 51.70M n/a n/a n/a
Rest Of Europe Revenue Growth -0.56% -0.76% +9.31% -2.01% +22.76% +30.38% +56.66% n/a n/a n/a n/a
United States Revenue 418.26M 372.35M 270.83M 225.76M 254.28M 242.24M 220.58M 154.76M n/a n/a n/a
United States Revenue Growth +12.33% +37.48% +19.97% -11.22% +4.97% +9.82% +42.54% n/a n/a n/a n/a

Operating Expense Breakdown

Quarter Sep 27, 2024Jun 28, 2024Mar 29, 2024Dec 31, 2023Sep 29, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022Sep 30, 2022Jul 1, 2022Apr 1, 2022Dec 31, 2021Oct 1, 2021Jul 2, 2021Apr 2, 2021Dec 31, 2020Oct 2, 2020Jul 3, 2020Apr 3, 2020Dec 31, 2019Sep 27, 2019Jun 28, 2019Mar 29, 2019Dec 31, 2018Sep 28, 2018Jun 29, 2018Mar 30, 2018Dec 31, 2017Sep 29, 2017Jun 30, 2017Mar 31, 2017Dec 31, 2016Sep 30, 2016Jul 1, 2016Apr 1, 2016Dec 31, 2015Oct 2, 2015Jul 3, 2015Apr 3, 2015
Selling, General, and Administrative Revenue 44.32M 44.79M 43.53M 41.70M 39.65M 42.19M 40.92M 38.71M 40.30M 40.54M 39.35M 34.97M 31.30M 31.24M 31.65M 27.40M 26.79M 24.91M 30.75M 29.43M 27.93M 29.20M 31.85M 28.30M 29.15M 29.23M 29.22M 27.36M 27.72M 23.94M 23.00M 19.33M 20.97M 20.20M 21.19M 19.08M 19.98M 20.92M 22.07M
Selling, General, and Administrative Revenue Growth -1.06% +2.90% +4.38% +5.18% -6.02% +3.09% +5.72% -3.95% -0.58% +3.01% +12.54% +11.73% +0.18% -1.30% +15.51% +2.29% +7.55% -19.01% +4.50% +5.39% -4.38% -8.30% +12.53% -2.90% -0.29% +0.04% +6.80% -1.32% +15.80% +4.09% +18.97% -7.81% +3.83% -4.67% +11.04% -4.50% -4.51% -5.19% n/a
Research and Development Revenue 23.25M 23.73M 23.25M 23.45M 22.02M 23.38M 22.83M 21.90M 21.35M 21.59M 20.93M 19.42M 17.47M 16.95M 18.68M 15.99M 15.23M 14.44M 15.33M 14.77M 13.81M 13.39M 14.00M 13.28M 13.20M 12.55M 11.99M 11.79M 11.66M 9.00M 9.21M 7.97M 7.96M 8.02M 8.05M 7.29M 7.69M 7.84M 8.21M
Research and Development Revenue Growth -2.01% +2.09% -0.88% +6.49% -5.81% +2.42% +4.22% +2.60% -1.11% +3.15% +7.78% +11.16% +3.03% -9.25% +16.83% +4.99% +5.48% -5.83% +3.83% +6.94% +3.16% -4.35% +5.40% +0.58% +5.20% +4.69% +1.64% +1.17% +29.49% -2.29% +15.58% +0.15% -0.69% -0.45% +10.38% -5.17% -1.88% -4.56% n/a